{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-285627","form_type":"8-K","ticker":"VOR","cik":"0001817229","company_name":"Vor Biopharma Inc.","filed_at":"2024-12-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.798648+00:00","generated_at":"2026-05-28T23:05:54.492325+00:00","sec_items":["1.01","3.02","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Vor Bio raises $55.6M in PIPE; extends cash runway to 2025 clinical data readouts","bullets":["Private placement of 55.87M shares and warrants for 69.84M shares at combined $0.99425 price, gross proceeds ~$55.6M.","New investor Reid Hoffman led; existing investor RA Capital participated; each gets one board seat and one observer seat.","Updated Phase 1/2 VCAR33 ALLO data expected H1 2025; Phase 1/2a trem-cel+Mylotarg data H2 2025.","Net proceeds to fund pipeline development and general corporate; warrant exercise could add $58.5M.","Warrants exercisable at $0.838/share, expire 7 years from issuance; closing expected Dec 30, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-285627","json":"https://secwatch.observer/filing/0001193125-24-285627.json","markdown":"https://secwatch.observer/filing/0001193125-24-285627.md","text":"https://secwatch.observer/filing/0001193125-24-285627.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1817229/000119312524285627/0001193125-24-285627-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1817229/000119312524285627/d865206d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T23:05:54.492325+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}